Watch CNBC's full interview with Teva Pharmaceuticals CEO Kare Schultz - YouTube
Kare Schultz, president and chief executive officer of Teva... News Photo - Getty Images
Teva poaches Lundbeck's Schultz as new CEO - PMLiVE
After turbulent years, Teva CEO Schultz forecasts stability - Israel News - The Jerusalem Post
A Look At Kare Schultz, The New CEO In Charge Of Teva
Teva Punished After Weak Outlook (NYSE:TEVA) | Seeking Alpha
Teva finally nabs a CEO, and it's Lundbeck helmsman—and Novo ex—Kåre Schultz | Fierce Pharma
Teva CEO Kare Schultz's pay fell in 2021 - Globes
Teva Appoints New Chief Executive After Months of Speculation - WSJ
Teva to Settle US Opioid Lawsuits for $4.35 Billion | The Jewish Press - JewishPress.com | David Israel | 28 Tammuz 5782 – July 27, 2022 | JewishPress.com
Teva CEO: Company Would Have Gone Bankrupt Without Layoffs - Business - Haaretz.com
Troubled Teva Hires CEO with Turnaround Experience - Hamodia.com
Kåre Schultz - Disability:IN
Teva CEO Says Drugmaker Will Fight US Price-Fixing Charges (2)
Ambassador views Teva CEO as important player in potential vaccine alliance
Teva Names Kare Schultz as President and Chief Executive Officer - Pharmaceutical Processing World
Teva sees return to growth after opioid settlement, shares jump | Reuters
Kåre Schultz is Named New President & CEO of Teva Pharmaceutical
Teva Abandons Search to Make Covid-19 Vaccine for Partners - Bloomberg
Teva CEO Kare Schultz: We're on track for financial goals - Globes
Parsippany-based Teva reaches $225M opioid settlement with Texas - NJBIZ
Teva CEO on decimated share price: "It's rational enough from a market point of view"
Watch CNBC's full interview with Teva CEO Kåre Schultz
